CSIMarket
 


Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

DGX's Capital Expenditures Growth by Quarter and Year

Quest Diagnostics Inc's Capital Expenditures results by quarter and year




DGX Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 162.00 172.00 151.00
III Quarter September - 91.00 96.00 159.00
II Quarter June - 82.00 85.00 78.00
I Quarter March 86.00 83.00 47.00 73.00
FY   86.00 418.00 400.00 461.00



DGX Capital Expenditures first quarter 2021 Y/Y Growth Comment
Quest Diagnostics Inc reported Capital Expenditures growth of 3.61% year on year in the first quarter, to $ 86.00 millions, this is lower than Quest Diagnostics Inc's recent average Capital Expenditures increase of 12.41%.

Looking into first quarter results within Medical Laboratories industry 13 other companies have achieved higher Capital Expenditures growth. While Quest Diagnostics Inc' s Capital Expenditures increase of 3.61% ranks overall at the positon no. 793 in the first quarter.




DGX Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -5.81 % 13.91 % 84.15 %
III Quarter September - -5.21 % -39.62 % 152.38 %
II Quarter June - -3.53 % 8.97 % 20 %
I Quarter March 3.61 % 76.6 % -35.62 % 73.81 %
FY   - 4.5 % -13.23 % 82.94 %

Financial Statements
Quest Diagnostics Inc's first quarter 2021 Capital Expenditures $ 86.00 millions DGX's Income Statement
Quest Diagnostics Inc's first quarter 2020 Capital Expenditures $ 83.00 millions Quarterly DGX's Income Statement
New: More DGX's historic Capital Expenditures Growth >>


DGX Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 78.02 % 79.17 % -5.03 %
III Quarter September - 10.98 % 12.94 % 103.85 %
II Quarter June - -1.2 % 80.85 % 6.85 %
I Quarter March -46.91 % -51.74 % -68.87 % -10.98 %
FY (Year on Year)   - 4.5 % -13.23 % 82.94 %




Capital Expenditures first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #14
Healthcare Sector #160
Overall #793

Capital Expenditures Y/Y Growth Statistics
High Average Low
152.38 % 12.41 % -62.92 %
(Sep 30 2018)   (Dec. 31, 2012)
Capital Expenditures first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #14
Healthcare Sector #160
Overall #793
Capital Expenditures Y/Y Growth Statistics
High Average Low
152.38 % 12.41 % -62.92 %
(Sep 30 2018)   (Dec. 31, 2012)

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Quest Diagnostics Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
177.05 % 17.67 % -81.43 %
(Sep 30 2015)  


DGX's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2021 Quest Diagnostics Inc disclosed fall in Capital Expenditures from the previous quarter by -46.91% to $ 86.00 millions, from $ 162.00 millions released a quarter before.

If you analyse recent shortcoming at the I. Quarter, you should assume, that usually I. Quarter 2021 results emerge weaker relative to the forth quarter, Archie  T. Walker, a business insider mentioned.

Within Medical Laboratories industry only one company achieved higher sequential Capital Expenditures growth. While Quest Diagnostics Inc's Capital Expenditures growth quarter on quarter, overall rank is 120.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #10
Overall #120
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #10
Overall #120
Capital Expenditures Q/Q Growth Statistics
High Average Low
177.05 % 17.67 % -81.43 %
(Sep 30 2015)  


DGX's I. Quarter Q/Q Capital Expenditures Comment
In the I. Quarter 2021 Quest Diagnostics Inc disclosed fall in Capital Expenditures from the forth quarter by -46.91% to $ 86.00 millions, from $ 162.00 millions released a quarter before.

When you look into current shortcoming in the quarter, you must presume, that commonly I. Quarter performance occur sluggish in contrast to the forth quarter

Within Medical Laboratories industry only one company achieved higher sequential Capital Expenditures growth. While Quest Diagnostics Inc's Capital Expenditures growth quarter on quarter, overall rank is 120.


Quest Diagnostics Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Capital Expenditures 12 Months Ending $ 421.00 $ 418.00 $ 428.00 $ 433.00 $ 436.00
Y / Y Capital Expenditures Growth (TTM) -3.44 % 4.5 % 12.93 % 18.96 % 22.13 %
Year on Year Capital Expenditures Growth Overall Ranking # 58 # 374 # 953 # 48 # 986
Seqeuential Capital Expenditures Change (TTM) 0.72 % -2.34 % -1.15 % -0.69 % 9 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 84 # 565 # 1297 # 917 # 769




Cumulative Capital Expenditures growth Comment
For the 12 months ended Mar 31 2021 Quest Diagnostics Inc reported a decrease in Capital Expenditures by -3.44% year on year, to $421 millions, compare to the 4.5% growth at Dec 31 2020.

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 58, from total ranking in previous quarter at 374.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1907.54 %
44.01 %
-35.8 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 4
Overall # 58

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
2069.62 %
53.36 %
-54.11 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 10
S&P 500 # 84
Cumulative Capital Expenditures growth Comment
For the 12 months ended Mar 31 2021 Quest Diagnostics Inc reported a decrease in Capital Expenditures by -3.44% year on year, to $421 millions, compare to the 4.5% growth at Dec 31 2020.

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 58, from total ranking in previous quarter at 374.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
1907.54 %
44.01 %
-35.8 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 4
Overall # 58

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
2069.62 %
53.36 %
-54.11 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 10
S&P 500 # 84




Other Capital Expenditures Growth
Medical Laboratories Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
DGX's Capital Expenditures Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for DGX's Competitors
Capital Expenditures Growth for Quest Diagnostics Inc's Suppliers
Capital Expenditures Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Comparisons



Companies with similar Capital Expenditures decrease for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2021
Aptose Biosciences Inc 6.25%$ 6.250 millions
Merus N v 6.08%$ 6.081 millions
Community Health Systems Inc 6.06%$ 6.061 millions
Hologic Inc6.04%$ 6.044 millions
Iqvia Holdings Inc 5.67%$ 5.674 millions
Mallinckrodt Plc5.03%$ 5.025 millions
Catalent Inc 4.56%$ 4.560 millions
Inogen Inc 4.26%$ 4.260 millions
Quest Diagnostics Inc3.61%$ 3.614 millions
Surmodics Inc 2.19%$ 2.188 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PK's Profile

Stock Price

PK's Financials

Business Description

Fundamentals

Charts & Quotes

PK's News

Suppliers

PK's Competitors

Customers & Markets

Economic Indicators

PK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071